AI-28568/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1992	1
1993	2
1994	3
1996	2
1997	4
2000	1
2001	2
2002	1
2003	1
2004	1
2024	0

1

Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes.

Yang OO, Kalams SA, Rosenzweig M, Trocha A, Jones N, Koziel M, Walker BD, Johnson RP. Yang OO, et al. J Virol. 1996 Sep;70(9):5799-806. doi: 10.1128/JVI.70.9.5799-5806.1996. J Virol. 1996. PMID: 8709196 Free PMC article.

2

Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses.

Yu XG, Shang H, Addo MM, Eldridge RL, Phillips MN, Feeney ME, Strick D, Brander C, Goulder PJ, Rosenberg ES, Walker BD, Altfeld M; HIV Study Collaboration. Yu XG, et al. AIDS. 2002 Feb 15;16(3):321-8. doi: 10.1097/00002030-200202150-00002. AIDS. 2002. PMID: 11834942

3

The rationale for immunotherapy in HIV-1 infection.

Walker BD. Walker BD. J Acquir Immune Defic Syndr (1988). 1994;7 Suppl 1:S6-13. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8182510 Review.

4

Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor.

Harrer E, Harrer T, Barbosa P, Feinberg M, Johnson RP, Buchbinder S, Walker BD. Harrer E, et al. J Infect Dis. 1996 Feb;173(2):476-9. doi: 10.1093/infdis/173.2.476. J Infect Dis. 1996. PMID: 8568316

5

Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.

Jassoy C, Harrer T, Rosenthal T, Navia BA, Worth J, Johnson RP, Walker BD. Jassoy C, et al. J Virol. 1993 May;67(5):2844-52. doi: 10.1128/JVI.67.5.2844-2852.1993. J Virol. 1993. PMID: 7682629 Free PMC article.

6

The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia.

Delgado JC, Leung JY, Baena A, Clavijo OP, Vittinghoff E, Buchbinder S, Wolinsky S, Addo M, Walker BD, Yunis EJ, Goldfeld AE. Delgado JC, et al. Immunogenetics. 2003 Oct;55(7):497-501. doi: 10.1007/s00251-003-0604-7. Epub 2003 Sep 27. Immunogenetics. 2003. PMID: 14517700

7

Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.

Johnson RP, Hammond SA, Trocha A, Siliciano RF, Walker BD. Johnson RP, et al. J Virol. 1994 May;68(5):3145-53. doi: 10.1128/JVI.68.5.3145-3153.1994. J Virol. 1994. PMID: 7908700 Free PMC article.

8

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.

Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'Aquila RT, Kurnick JT, Walker BD. Kalams SA, et al. J Exp Med. 1994 Apr 1;179(4):1261-71. doi: 10.1084/jem.179.4.1261. J Exp Med. 1994. PMID: 8145043 Free PMC article.

9

Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.

Yang OO, Tran AC, Kalams SA, Johnson RP, Roberts MR, Walker BD. Yang OO, et al. Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11478-83. doi: 10.1073/pnas.94.21.11478. Proc Natl Acad Sci U S A. 1997. PMID: 9326635 Free PMC article.

10

Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS Clinical Trials Groups 209 and 214.

Schooley RT, Spino C, Kuritzkes D, Walker BD, Valentine FA, Hirsch MS, Cooney E, Friedland G, Kundu S, Merigan TC Jr, McElrath MJ, Collier A, Plaeger S, Mitsuyasu R, Kahn J, Haslett P, Uherova P, deGruttola V, Chiu S, Zhang B, Jones G, Bell D, Ketter N, Twadell T, Chernoff D, Rosandich M. Schooley RT, et al. J Infect Dis. 2000 Nov;182(5):1357-64. doi: 10.1086/315860. Epub 2000 Oct 9. J Infect Dis. 2000. PMID: 11023459 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year